These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21608001)

  • 1. Dr. Jekyll and Mr. Hyde: a paradoxical oncogenic and tumor suppressive role of signal transducer and activator of transcription 3 in liver cancer.
    Calvisi DF
    Hepatology; 2011 Jul; 54(1):9-12. PubMed ID: 21608001
    [No Abstract]   [Full Text] [Related]  

  • 2. p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
    Schneller D; Machat G; Sousek A; Proell V; van Zijl F; Zulehner G; Huber H; Mair M; Muellner MK; Nijman SM; Eferl R; Moriggl R; Mikulits W
    Hepatology; 2011 Jul; 54(1):164-72. PubMed ID: 21452288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 10. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
    Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB: tumor promoter or suppressor?
    Perkins ND
    Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
    Demoulin JB; Van Snick J; Renauld JC
    Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclin-dependent kinase 4 inhibitor a and tumor].
    Gong Z; Fu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):219-21. PubMed ID: 11402455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor suppressor RB gene and its related molecules in hepatocellular carcinoma].
    Nishida N; Fukuda Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():134-7. PubMed ID: 11761929
    [No Abstract]   [Full Text] [Related]  

  • 15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor protein p16INK4a.
    Serrano M
    Exp Cell Res; 1997 Nov; 237(1):7-13. PubMed ID: 9417860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.
    Sun X; Zhang J; Wang L; Tian Z
    Cancer Lett; 2008 Apr; 262(2):201-13. PubMed ID: 18248786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis.
    Syed Z; Cheepala SB; Gill JN; Stein J; Nathan C; Digiovanni J; Batra V; Adegboyega P; Kleiner HE; Clifford JL
    Cancer Prev Res (Phila); 2009 Oct; 2(10):903-11. PubMed ID: 19789299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas.
    Simon M; Voss D; Park-Simon TW; Mahlberg R; Köster G
    Oncol Rep; 2006 Jul; 16(1):127-32. PubMed ID: 16786135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.